Literature DB >> 11160007

Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli O157:H7 infection in infant rabbits.

M Ogawa1, K Shimizu, K Nomoto, M Takahashi, M Watanuki, R Tanaka, T Tanaka, T Hamabata, S Yamasaki, Y Takeda.   

Abstract

We examined colonization patterns of Shiga toxin-producing Escherichia coli (STEC), concentrations of Shiga toxins (Stxs) and specific immunoglobulin A (lgA) against Stxs and STEC bacterial cell surface antigen in various portions of the gastrointestinal tract in an infant rabbit infection model. After inoculation of 3-day-old infant rabbits with STEC strain 89020087 at low doses (approximately 10(3) CFU/body), numbers of colonizing STEC bacteria and concentrations of Stxs in the intestine increased dramatically and the animals developed diarrhea within a couple of days after infection. Daily administration of Lactobacillus casei from the day of birth dramatically decreased the severity of diarrhea and lowered STEC colonization levels in the gastrointestinal tract 100-fold day 7 after infection. Both Stx1 and Stx2 concentrations in the intestines and histological damage to the intestinal mucus induced by STEC infection were decreased by the administration of L. casei. Examination of the concentrations of volatile fatty acids and pH of the intestinal contents revealed that the protective effect of L. casei administration against STEC infection was not due to fermented products such as lactic acid in the gastrointestinal tract. Administration of L. casei increased levels of lgAs against Stx1, Stx2, and formalin-killed STEC cells in the colon approximately two-, four-, and threefold, respectively, compared with those of the untreated controls by day 7 after infection. These results suggest that administration of L. casei strain Shirota enhances the local immune responses to STEC cells and Stxs and leads to elimination of STEC and thus decreases Stx concentrations in the intestines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160007      PMCID: PMC97991          DOI: 10.1128/IAI.69.2.1101-1108.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  64 in total

1.  Mucosal and systemic responses following enteric exposure to lactic acid bacteria.

Authors:  P M Norton; H W Brown; R W Le Page
Journal:  Adv Exp Med Biol       Date:  1995       Impact factor: 2.622

2.  Prevention of gastrointestinal infection using immunobiological methods with milk fermented with Lactobacillus casei and Lactobacillus acidophilus.

Authors:  G Perdigon; M E Nader de Macias; S Alvarez; G Oliver; A A Pesce de Ruiz Holgado
Journal:  J Dairy Res       Date:  1990-05       Impact factor: 1.904

3.  Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II.

Authors:  E A Wadolkowski; L M Sung; J A Burris; J E Samuel; A D O'Brien
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

4.  Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection.

Authors:  S Hudault; V Liévin; M F Bernet-Camard; A L Servin
Journal:  Appl Environ Microbiol       Date:  1997-02       Impact factor: 4.792

5.  Role of Shiga-like toxin I in bacterial enteritis: comparison between isogenic Escherichia coli strains induced in rabbits.

Authors:  R Sjogren; R Neill; D Rachmilewitz; D Fritz; J Newland; D Sharpnack; C Colleton; J Fondacaro; P Gemski; E Boedeker
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

6.  [Hand-rearing of rabbits using rabbit milk and commercial milk powder, Teo milk (author's transl)].

Authors:  M Akuzawa; N Matsunuma; Y Suzuki
Journal:  Jikken Dobutsu       Date:  1978-10

7.  Mucosal immune response to RDEC-1 infection: study of lamina propria antibody-producing cells and biliary antibody.

Authors:  C E McQueen; E C Boedeker; M Le; Y Hamada; W R Brown
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

8.  Evaluation of antinfective activity of an association bifidobacterium/lactobacillus in mouse intestine.

Authors:  G A Fichera; C Pappalardo; P M Furneri; M R Gismondo; G Nicoletti
Journal:  G Batteriol Virol Immunol       Date:  1987 Jan-Dec

9.  Augmentation of host resistance to Listeria monocytogenes infection by Lactobacillus casei.

Authors:  K Nomoto; S Miake; S Hashimoto; T Yokokura; M Mutai; Y Yoshikai; K Nomoto
Journal:  J Clin Lab Immunol       Date:  1985-06

10.  Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice.

Authors:  A R Melton-Celsa; S C Darnell; A D O'Brien
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

View more
  31 in total

1.  Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection.

Authors:  T Asahara; K Nomoto; M Watanuki; T Yokokura
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 2.  Trends in dairy and non-dairy probiotic products - a review.

Authors:  Bathal Vijaya Kumar; Sistla Venkata Naga Vijayendra; Obulam Vijaya Sarathi Reddy
Journal:  J Food Sci Technol       Date:  2015-03-13       Impact factor: 2.701

Review 3.  Designer probiotics: Development and applications in gastrointestinal health.

Authors:  Roy D Sleator
Journal:  World J Gastrointest Pathophysiol       Date:  2015-08-15

4.  pH-, Lactic acid-, and non-lactic acid-dependent activities of probiotic Lactobacilli against Salmonella enterica Serovar Typhimurium.

Authors:  Domitille Fayol-Messaoudi; Cédric N Berger; Marie-Hélène Coconnier-Polter; Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Appl Environ Microbiol       Date:  2005-10       Impact factor: 4.792

5.  Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements.

Authors:  Philip M Sherman; Kathene C Johnson-Henry; Helen P Yeung; Peter S C Ngo; Jacques Goulet; Thomas A Tompkins
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 6.  The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

Review 7.  Engineering microbes for targeted strikes against human pathogens.

Authors:  In Young Hwang; Hui Ling Lee; James Guoxian Huang; Yvonne Yijuan Lim; Wen Shan Yew; Yung Seng Lee; Matthew Wook Chang
Journal:  Cell Mol Life Sci       Date:  2018-05-07       Impact factor: 9.261

8.  The locus of enterocyte effacement-encoded effector proteins all promote enterohemorrhagic Escherichia coli pathogenicity in infant rabbits.

Authors:  Jennifer M Ritchie; Matthew K Waldor
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

9.  Coevolution of bacteriophage PP01 and Escherichia coli O157:H7 in continuous culture.

Authors:  Katsunori Mizoguchi; Masatomo Morita; Curt R Fischer; Masatoshi Yoichi; Yasunori Tanji; Hajime Unno
Journal:  Appl Environ Microbiol       Date:  2003-01       Impact factor: 4.792

10.  Effect of Lactobacillus Strains on Intestinal Microflora and Mucosa Immunity in Escherichia coli O157:H7-Induced Diarrhea in Mice.

Authors:  Xin Bian; Ting-Ting Wang; Min Xu; Smith Etareri Evivie; Guang-Wen Luo; Hong-Zhang Liang; Shang-Fu Yu; Gui-Cheng Huo
Journal:  Curr Microbiol       Date:  2016-03-30       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.